Phase I trial using weekly administration of gemcitabine and docetaxel in patients with advanced pancreatic carcinoma. [electronic resource]
Producer: 20050526Description: 289-96 p. digitalISSN:- 0009-3157
- Aged
- Antimetabolites, Antineoplastic -- administration & dosage
- Antineoplastic Agents, Phytogenic -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Carcinoma -- drug therapy
- Deoxycytidine -- administration & dosage
- Docetaxel
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Female
- Health Status
- Humans
- Male
- Middle Aged
- Neoplasm Metastasis
- Pain Measurement
- Pancreatic Neoplasms -- drug therapy
- Quality of Life
- Severity of Illness Index
- Taxoids -- administration & dosage
- Gemcitabine
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article
There are no comments on this title.
Log in to your account to post a comment.